Ibogaine: Myth Vs. Fact

This document provides a concise overview of ibogaine, a plant-derived drug used in some countries for opioid withdrawal but classified as a Schedule I substance in the US due to safety concerns and lack of accepted medical use. It dispels common myths about ibogaine, highlighting serious risks such as life-threatening heart problems and the absence of evidence for long-term benefits in treating opioid or stimulant use disorders. The document compares ibogaine to FDA-approved treatments, emphasizing that safer and more cost-effective options like buprenorphine and methadone are available and covered by Medicaid.

Click HERE to DOWNLOAD for FREE